Moderna
MRNA
#219
Rank
C$144.09 B
Marketcap
C$360.93
Share price
13.11%
Change (1 day)
977.74%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -C$4.25 Billion

According to Moderna 's latest financial reports the company's current earnings are C$2.21 Billion. In 2025 the company made an earning of -C$3.86 Billion, an increase over its 2024 earnings that were of -C$5.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$4.25 Billion10.05%
2025 -C$3.86 Billion-23.03%
2024 -C$5.01 Billion-8.22%
2023 -C$5.46 Billion-140.65%
2022 C$13.41 B-27.81%
2021 C$18.58 B-1911.15%
2020 -C$1.03 Billion44.7%
2019 -C$0.71 Billion28.63%
2018 -C$0.56 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.15 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$17.66 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$10.74 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$66.26 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$58.34 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.70 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-C$0.23 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA